The invention provides compounds of formula (I), ##STR00001## the pharmaceutically acceptable salts and solvates thereof, wherein A, B, R.sup.1, R.sup.2, and R.sup.7 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof as vasopressin V.sub.1A antagonists.